Becton, Dickinson and Company (LON:0R19)
Market Cap | 36.09B |
Revenue (ttm) | 16.15B |
Net Income (ttm) | 1.16B |
Shares Out | n/a |
EPS (ttm) | 4.00 |
PE Ratio | 31.12 |
Forward PE | 12.13 |
Dividend | 3.11 (1.84%) |
Ex-Dividend Date | Jun 9, 2025 |
Volume | 190 |
Average Volume | 6,024 |
Open | 170.00 |
Previous Close | 169.43 |
Day's Range | 169.68 - 171.08 |
52-Week Range | 163.64 - 251.08 |
Beta | 0.28 |
RSI | 37.57 |
Earnings Date | Aug 7, 2025 |
About LON:0R19
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system... [Read more]
Financial Performance
In 2024, LON:0R19's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.
Financial numbers in USD Financial StatementsNews

New Jersey Rep. Thomas Kean Bought Over $4K Worth of Amazon.com Stock: Here's What You Should Know
An official report on June 17, 2025 reveals Representative Thomas Kean's recent purchase of Amazon.com (NASDAQ: AMZN) stock, valued between $4,004 and $60,000. The transaction took place on May 8, 20...
Becton, Dickinson: A Dividend King Facing Challenges Offers Value

June's Top Dividend Aristocrat Fat Pitches: Blue-Chip Bargains You Can't Miss
Despite bubble fears, 91% of market gains since 2009 are justified by fundamentals like earnings, dividends, and strong balance sheets. Stocks appear overvalued at face value, but strong long-term ear...

June's Dividend Kings: 3 Ideal Buys In 25 "Safer" Dogs
Most Dividend Kings are currently overpriced, but six offer fair value where annual dividends from $1,000 invested exceed their share price. Three top-yield Dividend Kings—Altria, Northwest Natural, a...

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
FRANKLIN LAKES, N.J. , May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data regist...

Best Dividend Aristocrats For June 2025
Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 20...

BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference
FRANKLIN LAKES, N.J. , May 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman Sac...

Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'
FRANKLIN LAKES, N.J. , May 21, 2025 /PRNewswire/ -- First-of-their-kind studies published in The Lancet Oncology 1 and Cancer Medicine 2 provide new data showing that cancer patients in both hospital ...

35 Barron's Pro-Picks: One Ideal May DiviDog
Barron's interviewed eleven financial industry Roundtable-pros who tapped 65 predictions. Six non-ADR foreign-stocks and four mutual funds were dropped by YCharts screens of active US listings, leavin...
Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript)
Becton, Dickinson and Company (NYSE:BDX) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ETCompany ParticipantsTom Polen -...

BD to Announce Financial Results for its Third Quarter of Fiscal 2025
FRANKLIN LAKES, N.J. , May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio w...

The Best Health Care Stocks to Buy
The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.

Buy 3 "Safer" Dividend Kings Of 25 From May's 55
The May collection of Dividend Kings grew to 55, with Automatic Data Processing and RLI Corporation joining, despite two companies dropping off for not increasing dividends. Six top-yield Dividend Kin...

Block, Becton Dickinson And Pilgrim's Pride Are Among Top 10 Large-Cap Losers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Full story available on Benzinga.com

Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years
Becton Dickinson, and Company (NYSE: BDX) lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday. The medical device company reported adjusted earnings per share of...

Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years
Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.
Becton, Dickinson downgraded at more firms following Q2 results

Stock Of The Day – Bullish Capitulation In Becton, Dickinson?
Shares of Becton, Dickinson and Company BDX are coming back a little on Friday. This follows Thursday's more than 18% drop.

9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next
I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-vo...
Becton, Dickinson drops after guidance cut; BofA, Wells Fargo downgrade
Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales
“It’s become clear that pressure on research spending increased in the second quarter and will likely persist through fiscal year 2025,” the company said.
Becton, Dickinson and Company (BDX) Q2 2025 Earnings Call Transcript

Potential Tariff Bites Into Becton Dickinson 2025 Profit Outlook, Company Will Invest $2.5 Billion To Boost US Manufacturing
Becton, Dickinson, and Company (NYSE: BDX) lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday . The medical device giant reported adjusted earnings per share of...

Potential Tariff Bites Into Becton Dickinson 2025 Profit Outlook, Company Will Invest $2.5 Billion To Boost US Manufacturing
Becton, Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.